Posted in | News | Solar Energy | Green Energy

Magnolia Solar Receives US Patent on Roll-to-Roll Process for Fabricating Solar Cells

Magnolia Solar Corporation announced today that its wholly owned subsidiary, Magnolia Solar, Inc., was recently issued a patent by the United States Patent and Trademark Office (USPTO).

Magnolia Solar, Inc. is the assignee of US Patent No. 8,865,506 which describes a roll-to-roll process method for fabricating solar cells. The patent issued on October 21, 2014 and is designed to protect and enhance Magnolia's innovations in the field of flexible photovoltaics.

Magnolia Solar is actively working on the development of flexible, lightweight, high-efficiency solar cell technologies for a wide range of portable power applications. Magnolia Solar's technology portfolio includes nanostructured antireflection coatings, advanced photovoltaic absorber structures, and novel, low-cost manufacturing processes. The latest patent issued to Magnolia Solar describes a roll-to-roll solution process for fabricating flexible solar cells employing copper indium gallium selenide (CIGS) absorber materials.

Dr. Ashok K. Sood, President and CEO of Magnolia Solar, stated, "We have been aggressively pursuing more than a dozen US patent applications as a means to protect our intellectual property (IP) in the field of flexible photovoltaics. The 8,865,506 patent pertains to a novel manufacturing method utilizing roll-to-roll solution processes. This technology has the potential to significantly reduce the manufacturing costs associated with the production of flexible photovoltaic modules."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.